Loading clinical trials...
Loading clinical trials...
Effect of Use of Propofol Versus Use of Midazolam as Sedative Agent in Patients With Liver Cirrhosis Presented for Lower Gastrointestinal Endoscopy, Randomised Controlled Trial
propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy
Effect of use of propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy, Randomised controlled trial.
Age
45 - 65 years
Sex
ALL
Healthy Volunteers
No
Sherief Abd-Elsalam
Tanta, Egypt
Start Date
April 1, 2016
Primary Completion Date
November 11, 2022
Completion Date
December 11, 2022
Last Updated
August 27, 2018
100
ESTIMATED participants
Midazolam
DRUG
Propofol
DRUG
Lead Sponsor
Sherief Abd-Elsalam
NCT07343037
NCT05982769
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03208868